Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Dihydroergotamine Mesylate 0.2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, facilitating targeted treatment or absorption of the active ingredient.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dihydroergotamine Mesylate 0.2% Topical Gel is a specialized prescription medication, primarily used for the treatment of various conditions such as migraine headaches, cluster headaches, and other vascular headaches. This medication is a topical formulation of dihydroergotamine mesylate, a derivative of ergotamine, which functions as a vasoconstrictor. The gel is designed to be applied directly to the affected area, where it is absorbed through the skin, providing targeted treatment.
The mechanism of action of Dihydroergotamine Mesylate 0.2% Topical Gel involves the constriction of blood vessels in the affected area, which helps to reduce inflammation and alleviate pain. Additionally, it is believed to inhibit the release of certain neurotransmitters that are known to trigger headaches, further contributing to its effectiveness.
Generally, Dihydroergotamine Mesylate 0.2% Topical Gel is well tolerated by most patients, with minimal side effects. Some common side effects that may be experienced include skin irritation, redness, and itching. It is crucial to adhere to the instructions provided by your healthcare provider or pharmacist when using this medication to ensure its effectiveness and minimize potential side effects.
We encourage you to reach out to us if you have any queries or require further information about this medication.
Dihydroergotamine Mesylate 0.2% Topical Gel is a semisolid formulation specifically designed for the treatment of migraine and cluster headaches. It is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The active ingredients are absorbed through the skin, providing targeted treatment for the relief of headache symptoms.
It is crucial to understand that this medication is not intended for the treatment of other types of headaches, such as tension headaches. Additionally, it should not be used by patients with a history of stroke, heart attack, or other serious cardiovascular events. Potential side effects of this medication may include drowsiness, dizziness, or blurred vision. As such, patients are advised not to drive or operate machinery until they fully understand how this medication affects them.
Interactions may occur with other medications, including those containing ergot alkaloids like ergotamine, dihydroergotamine, or methysergide. Therefore, patients should inform their healthcare provider of all medications they are currently taking, including prescription and over-the-counter medications, vitamins, and herbal supplements.
Furthermore, this medication may interact with certain foods and beverages. Patients are advised to avoid alcohol consumption while on this medication. Foods or beverages containing caffeine should also be avoided as they may increase the risk of side effects.
If you have any questions or concerns about the use of Dihydroergotamine Mesylate 0.2% Topical Gel, please do not hesitate to reach out to your healthcare provider for further information and guidance.
Dihydroergotamine Mesylate 0.2% Topical Gel is a specialized prescription medication, primarily used for the treatment of severe migraine and cluster headaches. This medication functions by constricting the blood vessels surrounding the brain, which in turn reduces the inflammation and pain associated with these types of headaches.
The medication is a semisolid formulation that is dispensed through a pump mechanism. This design facilitates easy and precise application on the skin, allowing for targeted treatment. The active ingredients are absorbed through the skin in a gel-like consistency. The gel is typically applied directly to the skin of the forehead, temples, or back of the neck. It should be applied in a thin layer and gently rubbed in until it is completely absorbed.
It is crucial to avoid contact with the eyes, nose, and mouth when applying Dihydroergotamine Mesylate 0.2% Topical Gel. The medication should be used as soon as possible after the onset of a migraine or cluster headache. However, it is not recommended for use in children under 12 years of age.
As with any medication, it is important to follow the instructions of your healthcare provider when using Dihydroergotamine Mesylate 0.2% Topical Gel. If you have any questions or concerns about how to use this medication, it is recommended that you reach out to your healthcare provider or pharmacist for further guidance.
Dihydroergotamine Mesylate 0.2% Topical Gel is a semisolid formulation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, targeting the treatment area or facilitating the absorption of active ingredients in a gel-like consistency. This formulation has been utilized off-label for the management of various headache disorders, including chronic paroxysmal hemicrania, hemicrania continua, and new daily persistent headache. It has also been employed in the treatment of other conditions such as trigeminal neuralgia, occipital neuralgia, and chronic daily headache.
Furthermore, this formulation has been used off-label for the treatment of chronic pain conditions, such as fibromyalgia, and for the management of neuropathic pain. Therefore, any use of this formulation for these conditions should be done under the guidance of a healthcare professional. If you have any questions or concerns about the use of Dihydroergotamine Mesylate 0.2% Topical Gel for any of these conditions, it is recommended to consult with a healthcare provider.
Dihydroergotamine Mesylate 0.2% Topical Gel is a semisolid formulation of the medication Dihydroergotamine Mesylate. It is designed to be applied directly to the skin for targeted treatment.
This medication is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The medication has a gel-like consistency, which facilitates its application and absorption through the skin.
When applied to the skin, the active ingredients in the gel are absorbed into the body where they work to treat the condition for which they were prescribed.
You should apply this medication as directed by your healthcare provider. Typically, it is applied to the affected area of the skin and rubbed in gently until it is fully absorbed.
It is important to only apply this medication to the areas of the skin as directed by your healthcare provider. Avoid contact with eyes, mouth, and other sensitive areas.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Like all medications, Dihydroergotamine Mesylate 0.2% Topical Gel can cause side effects. These may include skin irritation at the application site. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Before using other skin products, consult with your healthcare provider. Some products may interfere with the absorption of Dihydroergotamine Mesylate 0.2% Topical Gel.
Store this medication at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
